维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Huls MH"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy 显示文摘	Huls MH Davis AR	2003	J Immunother2003，26，3：	1
2	Immunotherapy for Hodgkin's disease 显示文摘	Bollard C Huls MH	2002	Ann Hematol2002，81，2：	1
3	Autologous Epstein-Barr virus (EBV) -specific cytotoxic T cells for the treatment of persis- tent active EBV infection 显示文摘	Savoldo B Huls MH Liu Z	2002	Blood2002，100，12：	1
4	Autologous Epstein-Barus (EBV) specific cytotoxic T cells for the treatment of persistent active EBV infection显示文摘	Savoldo B Huls MH Liu ZS	2002	Blood2002，100，12：	1
5	Manufacture: of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor 显示文摘	Singh H Moyes JS Huls MH	2015	Cancer Gene Ther2015，22，2：	1
6	Prompt versus preemptive intervention for EBV lymphoproliferative disease 显示文摘	Wagner HJ Cheng YC Huls MH	2004	Blood2004，103，10：	1
7	Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection显示文摘	Savoldo B Huls MH Liu Z		0，，12：	1
8	Prompt versus preemptive intervention for EBV lymphoproliferative disease显示文摘	Wanger HJ Cheng YC Huls MH	2004	Blood2004，103，10：	1
9	CD20 monoelonal antibody (rituximab) for therapy of Epstein-Barr vires lymphoma after hemopoietic stemeell transplantation 显示文摘	Kuehnle I Huls MH Liu Z	2000	Blood2000，95，4：	1
10	Prompt versus preemptive intervention for EBV lymphoproliferative disease显示文摘	Wagner HJ Cheng YC Huls MH	2004	Blood2004，103，10：	1
11	CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation显示文摘	Kuehnle I Huls MH Liu Z	2000	Blood2000，95，4：	1
12	CD20 monoclonalanti- body(rituximab) for therapy of Epstein-Barr virus lym- phoma after hemopoietic stem-cell transplantation 显示文摘	Kuehnle I Huls MH Liu Z	2000	Blood2000，95，4：	1
13	Prompt versus preemptive intervention for EBV lymphoproliferative disease显示文摘	Wanger HJ Cheng YC Huls MH	2004	Blood2004，103，10：	1
14	Autologous Epstein-Barr virus (EBV)-specific cytotoxic T celts for the treatment of persistent active EBV infection 显示文摘	Savoldo B Huls MH Liu Z	2002	Blood2002，100，12：	1
15	The generation and char- acterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease 显示文摘	Bollard CM Straathof KC Huls MH	2004	J Immuno- ther2004，27，4：	1
16	Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection显示文摘	Savoldo B Huls MH Liu Z	2002	Blood2002，100，12：	1
17	Autologous Epstein-Barr virus(EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection显示文摘	Savoldo B Huls MH Liu Z	2002	Blood2002，100，12：	1
18	CD20 monoelonal antibody(rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietie stem-cell transplantation显示文摘	Kuehnle I Huls MH Liu Z	2000	Blood2000，95，4：	1
19	Autologous Epstein-Barr virus(EBV) -specific cytotoxic T cells for the treatment of persistent activeEBV infection显示文摘	Savoldo B Huls MH Liu Z	2003	Blood2003，100，12：	1
20	Large-scale expansion of den- dritic cell-primed polyclonal human eytotoxie T-lymphocytelines using lymphoblastoid cell lines for adoptive immunothera- py显示文摘	Sili U Huls MH Davis AR	2003	J Immunother2003，26，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示